WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that ICON (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has signed an agreement with Phase Forward under its CRO Advantage Program. The agreement will enable ICON to offer their clients Phase Forward’s market-leading electronic data capture (EDC) solution, InForm™.
